NetraMark to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Virtual corporate presentation available September 11, 2026 NetraMark management to hold in-person one-on-one investor meetings in New York City September 14th and 15th TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with AI-powered precision analytics in […]